<?xml version="1.0" encoding="UTF-8"?>
<p id="Par57">The under-performance of supply chains presents a significant hindrance to disease control in developing countries. Stock-outs of essential medicines lead to treatment interruption which can force changes in patient drug regimens, drive drug resistance and increase mortality. In the case of TB, stock-outs of anti-tuberculosis drugs lead to treatment interruption which can force changes in patient drug regimens, drive drug resistance and increase mortality [
 <xref ref-type="bibr" rid="CR16">16</xref>].
</p>
